基于PD-L1表达和瘤透淋巴细胞的免疫分类的预后影响在内腺癌中

Li-Jun Wei1, Zi-Yun Wu2, Li-Yan Wu1

  • 1Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Translational oncology
|December 30, 2024
PubMed
概括

宫内腺癌 (ECA) 亚型具有不同的免疫微环境. 瘤微环境免疫类型 (TMIT) 的分类,特别是非HPVA病例中的TMIT I,具有预后价值,可以预测免疫治疗反应.